|
Joanna Fogg-Waberski, M.D. and Witold Waberski, M.D.
(June 2000) -- Electroconvulsive therapy (ECT) remains one of the most controversial
treatments currently used in psychiatric practice despite its long-standing
record of safety and efficacy. This controversy has been fueled by attention
generated from the media, by the compelling testimony of former patients, and by
the nature and history of the treatment itself.1,2 A brief discussion of the
origins of ECT is helpful to understanding how this dramatic form of therapy
came to be incorporated in psychiatric practice and why it continues to be
enigmatic to both medical practitioners and the general public.
Historically, the therapeutic value of induced convulsions was not initially
linked to electricity but to other methods of inducing seizures. In the early
1930s, researchers in Europe induced convulsions by injections of insulin and
later with other drugs such as camphor in oil and Metrazol (a convulsive agent).
The first successful electroconvulsive treatment was described to the medical
world in 1938 when two Italian psychiatrists, Ugo Cerletti and Lucio Bini,
administered an electrical stimulus to induce convulsions in a human.
Since then, introducing ECT as a treatment in the United States has not been
an easy matter. The United States, after all, was the country that invented the
electric chair. Electrocution was used in this country for executing imprisoned
murderers. Cerletti and Bini's experiment with ECT was the only other
circumstance in which loss of consciousness had been induced purposefully via
electric current.3 Decades ago, patients underwent ECT without anesthesia.
Unmodified treatments did harm memory, so much so that memory loss came to be
seen as an essential part of the treatment. Some patients experienced bone
fractures from uncontrolled motor seizures induced by ECT. In addition to the
physical trauma, graphic examples of abuse in books and movies (eg, Ken Kesey's
"One Flew Over the Cuckoo's Nest") have portrayed ECT as punitive, cruel and
violative of patients' legal rights. One can understand the concerns that have
been linked to this form of therapy since its inception.4
With the introduction of anesthetic induction agents, muscle relaxants, and
monitoring, the adverse physical effects of ECT have been significantly
attenuated. This has made the procedure more acceptable to the medical community
and to the general public in North America. The description "electroconvulsive
therapy" came to be used in place of Cerletti's more disturbing term,
"electroshock treatment." In today's psychiatric practice, ECT typically
involves a series of six to 12 treatments of electrically induced grand mal
seizures administered
under general anesthesia to a patient with a severe
emotional disorder. Examples of mental illnesses which respond best to
ECT are
major depression with psychosis, acute
mania, and catatonia. Recent studies have
expanded treatment indications to other conditions such as Neuroleptic Malignant
Syndrome, Parkinsonism, and schizophrenia. While beneficial effects of
electrically induced seizures are evident and predictable in most patients, a
unified mechanism of action has not yet been established and remains the subject
of numerous investigations. ECT treatments can be administered on an inpatient
or outpatient basis depending on the severity of symptoms.
The most common side effect of ECT, feared by patients and their families, is
memory loss. Cognitive deficits are known to affect patients undergoing ECT.
These can be categorized as: acute, subacute, and long-term effects. Acute
disturbance of orientation and memory can take place immediately following ECT
with lasting effects from one to several hours. Subacute effects may persist for
days or weeks following completion of the course of ECT. Although there are
occasional anecdotal reports of permanent (long-term) memory loss,
substantiation of these reports remains a legitimate topic for longitudinal
study. Adverse cognitive effects of ECT have been reduced by the use of
standardized ECT equipment delivering brief pulse stimulation (as opposed to
sine wave stimulation). Unilateral electrode placement over the nondominant
hemisphere also significantly reduces the patient's exposure to post-ECT memory
loss. It is recommended that all patients undergoing ECT should have their
cognitive functions (particularly memory) closely monitored with mental status
assessments performed throughout the course of treatment. Occasionally, in
patients suffering from pre-existing cognitive impairment, detailed
neuropsychological testing pre- and post- ECT is necessary in order to
disentangle the effects of illness from those of the treatment.5
The current practice of ECT is considered safe and clinically effective. The
efficacy of ECT has been well established in study after study. The published
experience has been peer-reviewed and endorsed by commissions and task forces
delegated from the American Psychiatric Association and most recently from the
Office of the Surgeon General. The overall safety record of ECT has been
remarkable, especially when considering the risk to benefit ratio for patients
with severe emotional disorder who are actively suicidal or severely
malnourished. In the United States an estimated 100,000 patients per year
receive electroconvulsive treatment. In 1988, the mortality rate had been
reported at approximately one death per 10,000 patients treated. The rate of
significant morbidity and mortality at that time was believed to be lower with
ECT than with administration of antidepressant medications, despite the frequent
use of ECT in patients with medical complications and in the elderly.6,7 For
many elderly depressed patients with medical comorbidities, ECT is the safest
and most effective treatment available.
continue
top .
pages 1 2 .
send to friend .
depression site map
Reviewed: 01/2006
|
|